期刊文献+

结核分支杆菌katG蛋白的高表达与纯化 被引量:4

Overexpression and purification of catalase peroxidase katG from mycobacterium tuberculosis
原文传递
导出
摘要 目的 表达与纯化结核分支杆菌katG 蛋白,为深入研究异烟肼耐药机制奠定基础。方法 将含有katG 基因的pET24bkatG 表达载体转化大肠杆菌BL21(DE3) 菌株,在异丙基硫代βD半乳糖苷(IPTG) 诱导下表达,分别对不同诱导时间的表达产物进行SDSPAGE 以及考马斯亮蓝染色。获得稳定的高表达菌株后采用Xpress TM蛋白纯化系统对超声破菌液进行纯化。最后对纯化产物进行过氧化氢酶活性的初步检测。结果 对诱导后的重组大肠杆菌菌液进行十二烷基硫酸钠聚丙烯酰胺凝胶电泳(SDSPAGE) 以及考马斯亮蓝染色后发现相对分子质量约为80 000 。表达蛋白量约占总蛋白量的17.7% 。对重组katG基因表达产物进行纯化的结果发现,以350 m mol/L咪唑洗脱时的纯化效果最理想,蛋白纯度可达90 % 以上。对表达产物进行过氧化氢酶活性初步检测证明,重组的katG 基因产物具有过氧化氢酶活性。结论 通过pET24bkatG 表达质粒转化大肠杆菌可获得基因重组的katG 高表达菌株,表达产物具有一定酶活性。 Objective To express and purify the catalase peroxidase katG gene from mycobacterium tuberculosis. Methods Plasmid pET24b containing katG was transferred into competent Escherichia coli and katG gene was overexpressed by the challenge of isopropylthio β D glactoside(IPTG). The expression of katG protein was one step purified by Xpress system TM . Furthermore, the catalase activity of katG protein was preliminarily detected. Results The recombinant escherichia coli produced katG protein in large quantities, accounting for 17.7% of total cell protein. The molecular mass of katG protein was estimated to be 80 000 by sodium dodecyl sulfate polyacrylamide gradient gel electrophresis (SDS PAGE). It was found that imidazole at the concentration of 350 mmol/L could elute the katG protein most efficiently and yield the final preparation at greater than 90% purity. The katG protein was preliminarily detected to have the activity of catalase. Conclusions The stable katG overexpressing recombinant Escherichia coli can be constructed by the plasmid pET24b containing katG gene. The recombinant strain can produce katG protein with catalase activity and the product of which can be purified into higher activity.
出处 《中华传染病杂志》 CAS CSCD 北大核心 2000年第1期17-19,共3页 Chinese Journal of Infectious Diseases
基金 国家自然科学基金!资助项目(39970672)
关键词 结核分支杆菌 基因表达 KatG蛋白 异烟肼 Mycobacterium tuberculosis katG Gene expression Protein purification
  • 相关文献

参考文献6

  • 1Sambrook j Fritsch EF.分子克隆实验指南(第2版)[M].北京:科学出版社,1992..
  • 2Rouse D A,Mol Microbiol,1996年,22卷,583页
  • 3Rouse D A,Antimicrob Agents Chemother,1995年,39卷,2472页
  • 4Stoeckle M Y,JID,1993年,168卷,1063页
  • 5Zhang Y,Nature,1992年,358卷,591页
  • 6金冬雁(译),分子克隆实验指南(第2版),1992年

共引文献24

同被引文献60

  • 1李娟,吴雪琼,张俊仙,李香兰,张灵霞,梁建琴.结核分枝杆菌CFP10-ESAT6融合蛋白在大肠杆菌中的高效表达[J].中国防痨杂志,2004,26(4):204-208. 被引量:8
  • 2李素华,钟森,徐建国,史晓玲.结核杆菌Mtb8.4抗原在大肠杆菌中表达的初步研究[J].中国人兽共患病杂志,2005,21(2):156-158. 被引量:2
  • 3Murray CJ,Lopez AD.Mortality by cause for eight regions of the world:Global Burden of Disease Study[J].Lancet,1997,349 (9061):1269.
  • 4Kaufmann SH.How can immunology contribute to the control of tuberculosis[J].Nat Rev Immuno1,2001,1(1):20.
  • 5Fine P E.Variation in protection by BCG:implications of and for heterologous immunity[J].Lancet,1995,346 (8986):1339.
  • 6Zuber PL,McKenna MT,Binkin NJ,et al.Long-term risk of tuberculosis among foreign-born persons in the United States[J].JAMA,1997,278:304.
  • 7Mollenkopf HJ,Grode L,Mattow J,et al.Application of Mycobacterial Proteomics to Vaccine Design:Improved Protectionby Mycobacterium bovis BCG Prime-Rv3407 DNA Boost Vaccination against Tuberculosis[J].Infect immun,2004,72 (11):6471.
  • 8Naqai S,Wiker HG,Harboe M,et al.Isolation and partial characterization of major protein antigens in the culture fluid of Mycobacterium tuberculosis[J].Infect Immun,1991,59 (1):372.
  • 9van Pinxteren LA,Ravn P,Agger EM,et al.Diagnosis of tuberculosis based on the two specific antigens ESAT-6 and CFP10[J].Clin Diagn Lab Immunol,2000,7(2):155.
  • 10Dillon DC,Alderson MR,Day CH,et al.Molecular and immunological characterization of Mycobacterium tuberculosis CFP-10,an immunodiagnostic antigen missing in Mycobacterium bovis BCG[J].J Clin Microbiol,2000,38(9):3285.

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部